Related Experiment Videos
Minimal intermittent heparinization during hemodialysis.
Nephron
|January 1, 1979
Summary
Minimal heparinization effectively prevents blood loss during hemodialysis. This method significantly reduces heparin dosage, eliminating the need for protamine sulfate and infusion equipment, even in high-risk patients.
Area of Science:
- Nephrology
- Hematology
- Pharmacology
Background:
- Hemodialysis requires anticoagulation to prevent clotting.
- Conventional heparinization methods can lead to complications and require specific equipment.
- Optimizing anticoagulation strategies is crucial for patient safety and treatment efficiency.
Purpose of the Study:
- To compare minimal dose heparinization with conventional methods during hemodialysis.
- To evaluate the efficacy and safety of reduced heparinization.
- To assess the impact on blood loss, dosage, and complications.
Main Methods:
- Activated partial thromboplastin time (aPTT) monitored minimal heparinization.
- Compared minimal dose heparin with intermittent, continuous, and regional heparinization.
- Utilized coil dialyzers for hemodialysis treatment.
Main Results:
- Blood loss was comparable across all heparinization methods.
- Minimal heparinization markedly reduced overall heparin dosage.
- No bleeding complications occurred, even in high-risk patients.
- Eliminated the need for protamine sulfate and infusion equipment.
Conclusions:
- Minimal heparinization is a safe and effective anticoagulation strategy for hemodialysis.
- This approach significantly reduces heparin requirements and associated costs.
- It offers a practical alternative, especially for high-risk individuals, simplifying the procedure.